David Hoang

Stock Analyst at Deutsche Bank

(0.63)
# 2584
Out of 5,441 analysts
46
Total ratings
Success rate
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
HRMY Harmony Biosciences ...
Maintains: Strong Buy
54 55
34.83 57.91% 3 Jul 10, 2025
SRPT Sarepta Therapeutics
Maintains: Hold
50 25
17.95 39.28% 7 Jun 17, 2025
ACAD ACADIA Pharmaceutica...
Upgrades: Buy
20 35
24.83 40.96% 5 May 21, 2025
ALKS Alkermes
Maintains: Strong Buy
40 52
26.55 95.86% 2 Mar 27, 2025
XENE Xenon Pharmaceutical...
Initiates Coverage On: Buy
67
34.12 96.37% 3 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
111
44.96 146.89% 1 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
31
13.91 122.86% 3 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
65
13.43 383.99% 1 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
176
103.95 69.31% 4 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
12.79 -6.18% 1 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
150 158
123.99 27.43% 4 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
45 50
n/a n/a 3 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
7
1.41 396.45% 1 Jul 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
8
8.68 -7.83% 1 May 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
6.06 164.03% 1 Mar 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
3.08 419.48% 1 Mar 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
220
434.89 -49.41% 1 Apr 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
80
17.2 365.12% 1 Apr 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
15 25
24.98 0.08% 1 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
3
1.74 72.41% 1 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Apr 1, 2022